DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Combined Vitrectomy and Triamcinolone in Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)

Information source: Helse Stavanger HF
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Branch Retinal Vein Occlusion; Macular Edema

Intervention: Grid Laser (Procedure); Vitrectomy and 20 mg triamcinolone (Procedure)

Phase: Phase 3

Status: Terminated

Sponsored by: Helse Stavanger HF

Official(s) and/or principal investigator(s):
Johan Seland, PhD, Study Director, Affiliation: Helse Stavanger HF


The purpose of this study is to determine whether pars plana vitrectomy in combination with triamcinolone acetate is effective in the treatment of macular edema due to branch retinal vein occlusion.

Clinical Details

Official title: A Randomized Study Comparing Combined Vitrectomy and Triamcinolone to Laser Grid in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)

Study design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome: Visual acuity (ETDRS)

Secondary outcome: Retinal thickening measured on OCT.


Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.


Inclusion Criteria:

- Macular edema secondary to BRVO

- Best Corrected Visual Acuity of ≤ 20/40 on ETDRS chart

- Duration no shorter than 3 months

- Duration no longer than 12 months

Exclusion Criteria:

- Proliferations in study eye

- Blod in vitreous cavity

- Previous fundus laser treatment

- BRVO with over 180˚ of ischemia on FA

- Age under 18

- Other eye condition which contribute to relevant loss of visual acuity

Locations and Contacts

Stavanger University Hospital, Department of Ophthalmology, Stavanger 4018, Norway
Additional Information

Starting date: November 2006
Last updated: January 3, 2014

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017